Evaluation of Store-and-Forward Teledermatology Versus a Face-to-Face Assessment During a Skin Cancer Screening Event
1 other identifier
interventional
170
1 country
1
Brief Summary
The purpose of this study is to determine the diagnostic and management concordance of face-to-face dermatologist versus a store-and-forward teledermatologist at a skin cancer screening event. The investigators' hypotheses include the following:
- 1.Compared to in-person assessment, store-and-forward teledermatology assessment will result in adequate diagnostic concordance.
- 2.Compared to in-person assessment, store-and-forward teledermatology results in adequate management concordance.
- 3.The sensitivity and specificity of store-and-forward evaluation to detecting lesions that are either premalignant or malignant will be similar to that of in-person evaluation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Sep 2010
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2010
CompletedFirst Submitted
Initial submission to the registry
February 4, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2011
CompletedFirst Posted
Study publicly available on registry
March 28, 2013
CompletedJuly 19, 2017
March 1, 2013
9 months
February 4, 2011
July 17, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Aggregated diagnostic concordance
Aggregated diagnostic concordance which is defined as the agreement of the in-person dermatologist's principle diagnosis with the teledermatologist's primary diagnosis or any of the differential diagnoses.
At the time of dermatologist evaluation (Day 1)
Secondary Outcomes (5)
Primary diagnostic concordance
At the time of dermatologist evaluation (Day 1)
Categorical diagnostic concordance
At the time of dermatologist evaluation (Day 1)
Management concordance
At the time of dermatologist evaluation (Day 1)
Sensitivity
At the time of dermatologist evaluation (Day 1)
Specificity
At the time of dermatologist evaluation (Day 1)
Study Arms (2)
In-person dermatology evaluation
OTHERHealth care modality
Store-and-forward teledermatology evaluation
OTHERHealth care modality
Interventions
Every patient will be evaluated by an in person dermatologist present at the screening.
Every patient will be evaluated online via a store and forward teledermatology modality.
Eligibility Criteria
You may qualify if:
- years of age or older at time of consent, may be male or female.
- Able to provide a brief medical history and have/allow an examination of their skin including photographs.
- Capable of giving informed consent.
- Will be able to receive notification of follow-up recommendations
You may not qualify if:
- Patients who will not provide informed consent
- Patient who are unable to fulfill tasks of this study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of California, Davis Shifa Community Clinic
Sacramento, California, 95818, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
April W Armstrong, MD, MPH
University of California, Davis
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- SCREENING
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 4, 2011
First Posted
March 28, 2013
Study Start
September 1, 2010
Primary Completion
June 1, 2011
Study Completion
June 1, 2011
Last Updated
July 19, 2017
Record last verified: 2013-03